April 2014 | Contemporary Oncology®

Advances in Immunotherapy for the Treatment of Non-Small Cell Lung Cancer

April 25, 2014

The treatment decisions for NSCLC are primarily dependent on the patient's performance status, extent of disease, and histological subtype. Significant developments in the area of targeted therapies have changed the treatment paradigm for NSCLC.